Isaac Kohane (HMS) participated in an interview about Daniel MacArthur’s (Mass General) study on people who remain healthy even though they carry genetic variants known to cause severe Mendelian childhood diseases.
The Drug Enforcement Agency announced last week that it is reviewing the possibility of reclassifying marijuana as a Schedule II drug, which would put it in the same category as Ritalin, Adderall and oxycodone. Kevin Hill (McLean) is quoted.
Jonathan Hausmann (Boston Children’s) and John Brownstein (Boston Children’s) are researching a new way to diagnose a fever called ‘feverprints,’ associated with different illnesses to help doctors make quicker and more accurate diagnoses.
This article discusses the potential benefits and risks associated with the possibility of human gene editing. George Church (HMS) authored one response.
In order to improve treatment strategies for common conditions among former football players, the Football Players Health Study—led by a team of Harvard researchers — launched a smartphone app, TeamStudy. The app has two tracks, a survey of former NFL players to determine the health issues of greatest concern, and a simultaneous effort to find ways of addressing those issues. Alvaro Pascual-Leone (Beth Israel Deaconess) is quoted. Download the app here.
Pieter Cohen (Cambridge Health Alliance) led a study finding that a stimulant banned from competitive sports has been found in more than a dozen dietary supplements marketed for “burning” body fat.